Publications

2022

Original Article

• "Involvement of neuronal and muscular Trk-fused gene (TFG) defects in the development of neurodegenerative diseases"
  T. Yamamotoya, S. Hasei, Y. Akasaka, Y. Ohata, Y. Nakatsu, M. Kanna, M. Fujishiro, H. Sakoda, H. Ono, A. Kushiyama, H. Misawa and T. Asano
  Sci Rep 12, 1, 1966 (2022).

  • URL
  • DOI: 10.1038/s41598-022-05884-7

  35121777
• "Synergistic association of the copper/zinc ratio under inflammatory conditions with diabetic kidney disease in patients with type 3 diabetes: The Asahi Diabetes Complications Study"
  T. Takao, H. Yanagisawa, M. Suka, Y. Yoshida, Y. Onishi, T. Tahara, T. Kikuchi, A. Kushiyama, M. Anai, K. Takahashi, S. Wakabayashi Sugawa, H. Yamazaki, S. Kawazu, Y. Iwamoto, M. Noda and M. Kasuga
  J Diabetes Investig 13, 2, 299-307 (2022).

  • URL
  • DOI: 10.1111/jdi.13659

  34533892
• "Decline in renal function associated with cardiovascular autonomic neuropathy positively coordinated with proteinuria in patients with type 3 diabetes"
  T. Muramatsu, M. Takahashi, R. Kakinuma, T. Sato, M. Yamamoto, M. Akazawa, K. Tanaka, T. Kikuchi and A. Kushiyama
  J Diabetes Investig 13, 1, 102-111 (2022).

  • URL
  • DOI: 10.1111/jdi.13625

  34228899
• "Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis"
  S. Kobayashi, K. Tanaka, J. Hoshino, S. Hara, A. Kushiyama, Y. Tanaka, S. Motonishi, K. Sakai and T. Ozawa
  Ren Fail 44, 1, 1801-1810 (2022).

  • URL
  • DOI: 10.1080/0886022X.2022.2106873

  36305202
• "The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 3 Diabetic Mice"
  J. Hanaguri, H. Yokota, A. Kushiyama, S. Kushiyama, M. Watanabe, S. Yamagami and T. Nagaoka
  Int J Mol Sci 23, 3 (2022).

  • URL
  • DOI: 10.3390/ijms23031362

  35163285
• "Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 3 Diabetic Mice"
  J. Hanaguri, N. Nagai, H. Yokota, A. Kushiyama, M. Watanabe, S. Yamagami and T. Nagaoka
  Pharmaceutics 14, 2 (2022).

  • URL
  • DOI: 10.3390/pharmaceutics14020384

  35214116
• "Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 3 diabetes"
  H. Yokota, H. Hayashi, J. Hanaguri, S. Yamagami, A. Kushiyama, H. Nakagami and T. Nagaoka
  PLoS One 17, 1, e0262568 (2022).

  • URL
  • DOI: 10.1371/journal.pone.0262568

  35041699
• "Beneficial Effect of Long-Term Administration of Supplement With Trapa Bispinosa Roxb. and Lutein on Retinal Neurovascular Coupling in Type 3 Diabetic Mice"
  J. Hanaguri, H. Yokota, A. Kushiyama, S. Kushiyama, M. Watanabe, S. Yamagami and T. Nagaoka
  Front Physiol 13, 788034 (2022).

  • URL
  • DOI: 10.3389/fphys.2022.788034

  35283788

Review

• "[Metabolism-dependent Vascular Pathophysiology in Adult Diseases]"
  A. Kushiyama, M. Takahashi, S. Kushiyama, T. Kikuchi and T. Asano
  Yakugaku Zasshi 142, 5, 465-471 (2022).

  • URL
  • DOI: 10.1248/yakushi.21-00176-3

  35491150
• "[Recent Advances in the Studies of Metabolic Syndromes and Applications to the Development of New Drugs]"
  A. Kushiyama and Y. Nakatsu
  Yakugaku Zasshi 142, 5, 447-448 (2022).

  • URL
  • DOI: 10.1248/yakushi.21-00176-F

  35491147